- Humanitas signs document in defense of the freedom and independence of the scientific debate from the influence of the tobacco giants
- Clinic, research and teaching: Prof. Marcacci in an interview
- Active surveillance in bladder cancer: new study confirms validity
- Immunity and tumors: researcher Martina Molgora receives an award
- Advanced hepatocarcinoma: positive results from the Cabozantinib study, in which Humanitas also took part
- Sepsis: A protein predicts the prognosis and risk of mortality. The results of a study in which Humanitas also took part
- Hepatocarcinoma: the results of the Humanitas study published in The Lancet Oncology
- New diagnostic techniques in Gastroenterology: Professor Repici’s intervention at Wired Health
- The Image of Artificial Intelligence: Professor Chiti’s Speech at Wired Health
- Cancer and Research: “Moving Target”, the new book by Prof. Mantovani
- Ulcerative colitis, the first results of a new study with apremilast presented in Vienna by professor Danese
- Blood tumors and genome studies: in Humanitas a diagnostic test from a personalized medical point of view
- Severe Infarction: A New Therapeutic Opportunity from New Generation Anticoagulant Drugs
- The role of Research and future prospects: Prof. Mantovani on Rai Radio 1
- A new European study coordinated by Humanitas for the treatment of ALS is launched
- Psoriasis and psoriatic arthritis: a study on twins in Humanitas
- Tumors: Prof. Mantovani and Dr. Garlanda explain the discovery of IL-1R8, the new immunity brake
- Myelodysplastic syndromes: new drugs and personalized medicine
